U. Costabel (Essen, Germany), P. Camus (Dijon, France)
LATE-BREAKING ABSTRACT: Efficacy of inhaled N-acetylcystein in patients with interstitial pneumonia
R. Okuda, T. Ohba, T. Nishizawa, R. Kawabe, K. Honda, M. Amano, H. Matsushima (Saitama, Japan)
|   |
LATE-BREAKING ABSTRACT: Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF)
P. W. Noble, C. Albera, W. Z. Bradford, U. Costabel, R. M. du Bois, R. S. Fishman, I. Glaspole, M. K. Glassberg, L. Lancaster, D. Lederer, J. A. Leff, S. D. Nathan, C. A. Pereira, J. J. Swigris, DO, D. Valeyre, T. E. King, Jr. (Los Angeles, Brisbane, Miami, Nashville, New York, Falls Church, Denver, San Francisco, United States Of America; Turin, Italy; Essen, Germany; London, United Kingdom; Melbourne, Australia; São Paulo, Brazil; Bobginy, France)
| |
Idiopathic pulmonary fibrosis treatment: Combined pirfenidone + acetylcysteine vs N-acetylcysteine in monotherapy
C. Vitale, M. Lanza, G. Calabrese, G. Caccavo, M. D'Amato, A. A. Stanziola (Naples, Italy)
| |
Correlation of 18F-FDG PET/CT with inflammatory biomarkers in sarcoidosis
N. Koren Pucelj, M. Harlander, M. Grmek, B. Salobir, M. Zupancic, M. Tercelj (Ljubljana, Slovenia)
| |
CPFE (combined pulmonary fibrosis and emphysema): A case series
G. Calabrese, M. Martino, G. Caccavo, M. D'Amato, A. A. Stanziola (Naples, Italy)
| |
Does CTLA-4 and CD-28 polymorphism affect the lung involvement in Turkish ankylosing spondylitis patients??
F. Karakose, A. Rezvani, S. Turan, O. Uysal, M. E. Akkoyunlu, N. E. Ozkan, M. Bayram, H. Sozgen, F. Yakar, H. Ozcelik, M. Sezer, M. Guler, I. Yaylim, L. Kart (Istanbul, Turkey)
| |
Clinical course of patients with bronchiolitis obliterans after hematopoietic stem cell transplantation
M. Yomota, Y. Nakahara, Y. Okuma, Y. Takagi, S. Mikura, Y. Hosomi, J. Aoki, K. Ohashi, T. Okamura (Tokyo, Japan)
| |
Obliterative bronchiolitis post mycoplasma associated Stevens-Johnson syndrome
L. Nair, S. Moss (Newcastle, United Kingdom)
| |
Pulmonary embolism (PE) in patients with pulmonary sarcoidosis (PS)
O. Baranova, V. Perlei, A. Gichkin, V. Zolotnitskaya, A. Speranskaya (Saint-Petersburg, Russian Federation)
| |
30 years experience of plasmapheresis using in complex treatment of pulmonary sarcoidosis (PS)
O. Baranova, V. Voinov, O. Baklanova (Saint-Petersburg, Russian Federation)
| |
Castleman disease variant of atypical POEMS syndrome: A case presentatIon
Z. Isikdogan, A. Baha, N. Kokturk, H. Turktas, N. Akyurek, G. Sucak (Ankara, Turkey)
| |
The role of cardiac magnetic resonance in detection and monitoring of the treatment efficacy of heart involvement in EGPA patients
J. Fijolek, E. Wiatr, D. Gawryluk, U. Nowicka, J. Kober, D. Piotrowska-Kownacka, M. Szolkowska, K. Roszkowski-Sliz (Warsaw, Poland)
| |
Utility of bronchoalveolar lavage in vasculitis patients
J. Heaton, N. Naz, S. Hardy, J. Harper (Liverpool, United Kingdom)
| |
The value of bronchoalveolar lavage in the diagnosis and management of small airway disease
J. Kanazawa, T. Saito, M. Nakazawa, K. Fujita, H. Sakurai, K. Nemoto, S. Y. Lin, T. Takaku, K. Hayashihara (Tokai-mura, Japan)
| |
ANCA associated vasculitis – Evaluation of diagnosis, treatment and outcome in a group of 68 patients
I. Belaconi, C. Toma, S. Stancu, S. Dumitrache-Rujinski, C. Tudose, A. Croitoru, L. Grigoriu, D. Leonte, E. Magheran, M. Bogdan (Bucharest, Romania)
| |
Prevalence of chronic ischaemic heart disease in idiopathic pulmonary fibrosis: A single center study
M. Martino, M. Lanza, M. D'Amato, G. Caccavo, G. Calabrese, C. Vitale, A. A. Stanziola (Naples, Italy)
| |
Circulating C-reactive protein level is negatively correlated with lung volume
S. Kawase, S. Miyamoto, H. Ohnishi, T. Kubota, N. Ishikawa, Y. Haruta, N. Hattori, K. Yamane, N. Kohno, A. Yokoyama (Nankoku, Hiroshima, Japan)
| |